- Pregnant women
- HIV
- Antiretroviral therapy
- Perinatal transmission
- Pre-exposure prophylaxis
- Co-infections
- Nausea
- Drug interactions
- Nevirapine
- Adherence
- Viral load
- Breastfeeding
- Multidisciplinary
- Real-time assessment
- Formula feeding
- Cesarean delivery
- Neonatal antiretroviral therapy
- Contraception
- Psychosocial support
- Termination of pregnancy
- Virological status
- Obstetrical assessments
- Intrapartum management
- Zidovudine
- Surveillance programs
- Adverse pregnancy outcomes
- Fetal risks
- Maternal risks
- Viral load suppression
- Intended pregnancies
- Unintended pregnancies
- Low birth weight
- Preterm delivery
- NNRTIs
- INSTIs
- NRTIs
- Protease Inhibitors
- Integrase Strand Transfer Inhibitors
- Dolutegravir
- Elvitegravir
- Bictegravir
- Cabotegravir
- Efavirenz
- Rilpivirine
- Etravirine
- Doravirine
- Placental transfer
- Teratogenicity
- Acid suppression agents